Irritable Bowel Syndrome Treatment Guidelines

Introduction to IBS Treatment

• Irritable Bowel Syndrome (IBS) is a complex condition that requires a comprehensive management approach, including dietary modifications, lifestyle changes, and pharmacological interventions, as recommended by the American Gastroenterological Association 1
• Complete symptom resolution is often not achievable with medications alone, and efficacy of all drugs for IBS is modest, highlighting the importance of a multidisciplinary approach 1

First-Line Treatment

• Standard dietary modifications and lifestyle changes are recommended for patients with IBS, with treatment response assessed after 4+ weeks 1
• Dietary modifications, such as reducing spicy foods, caffeine, and alcohol, are recommended 2, 3
• A low FODMAP diet, implemented by a trained dietitian, can significantly reduce IBS symptoms including diarrhea, but must be carefully monitored for nutritional adequacy, especially in patients with IBD, as recommended by the American Gastroenterological Association and the British Dietetic Association 4, 5, 1
• Establish baseline fiber intake and gradually increase to 25g/day for constipation, as recommended by the American Gastroenterological Association 6, 2
• Reduce intake of gas-producing foods, such as those high in fiber, lactose, or fructose, to alleviate IBS symptoms, as recommended by the European Society for Clinical Nutrition and Metabolism 7

Second-Line Treatment

• Osmotic laxatives like polyethylene glycol are effective for constipation-predominant IBS, and antispasmodics may be used for pain-predominant symptoms 1
• Tricyclic antidepressants (TCAs) are strongly recommended as second-line therapy with moderate quality evidence, particularly effective for IBS-D and pain-predominant symptoms 5
• Antispasmodics, including dicyclomine, are primarily used for pain-predominant symptoms, and tricyclic antidepressants are particularly effective for diarrhea-predominant IBS, according to the British Society of Gastroenterology guidelines 5
• Peppermint oil may improve global symptoms and abdominal pain in patients with IBS-D 5

Third-Line Treatment

• For constipation-predominant IBS, secretagogues may be considered, and for severe or refractory symptoms, psychological therapies like gut-directed hypnotherapy may be effective 1
• Secretagogues like linaclotide have the strongest evidence for efficacy in IBS-C, but should be reserved for patients who fail first-line therapy, with linaclotide approved for all adults 8
• 5-HT3 receptor antagonists (ondansetron), rifaximin, and eluxadoline are options for IBS with diarrhea, and cholestyramine is recommended for bile salt malabsorption, which affects approximately 10% of diarrhea-predominant IBS patients, as suggested by the British Society of Gastroenterology guidelines 2, 5

Psychological Therapies

• Cognitive Behavioral Therapy (CBT) can be effective in 4-12 sessions, focusing on remediation of skills deficits, pain catastrophizing, and visceral anxiety, as suggested by the American Psychological Association 9, 10, 1, 6, 2
• Gut-directed hypnotherapy can focus on somatic awareness and down-regulation of pain sensations, as reported by the European Society for Neurogastroenterology and Motility 9, 1
• Mindfulness-based stress reduction can improve specific symptoms like constipation, diarrhea, bloating, and gastrointestinal-specific anxiety, according to the American Gastroenterological Association 9, 1
• Acceptance and commitment therapy can pair acceptance and mindfulness strategies with behavior change techniques, as suggested by the Association for Contextual Behavioral Science 9

Diagnostic Testing

• For persistent bloating, the American Gastroenterological Association suggests considering testing for small intestinal bacterial overgrowth (SIBO) with hydrogen/methane breath testing, based on moderate evidence 11
• Hydrogen and methane breath testing can be more effective than hydrogen testing alone for suspected SIBO, as recommended by the European Society for Neurogastroenterology and Motility 12
• Small bowel aspiration can be used for qualitative assessment of SIBO, according to the American Gastroenterological Association 12
• Faecal elastase-1 measurement (level <500μg/g may indicate PEI) can be used to diagnose pancreatic exocrine insufficiency, as suggested by the European Society for Neurogastroenterology and Motility 12

Treatment Approach and Monitoring

• Use a symptom diary to identify triggers and monitor response to treatment, as recommended by the American Gastroenterological Association 6, 2
• Consider referring patients to a gastroenterologist when diagnostic uncertainty exists, symptoms are severe or refractory to first-line treatments, or the patient requests a specialist opinion, with a strength of evidence level of moderate, as suggested by the American Gastroenterological Association 5
• Referring patients to a specialist dietitian may be beneficial for those with high intake of trigger foods, dietary deficits, or food-related fear, as suggested by the British Dietetic Association 1, 5
• Review efficacy after 3 months of treatment and discontinue if no response, as recommended by the American Gastroenterological Association 5
• Assess treatment response after 4+ weeks for first-line treatments 1
• For neuromodulators like amitriptyline, continue for at least 6 months in those who respond to treatment 1

Stepwise Treatment Approach